期刊文献+

磺达肝癸钠与依诺肝素的治疗对比分析 被引量:6

下载PDF
导出
摘要 目的本研究观察在接受经皮冠脉介入治疗(PCI)的非ST段抬高的急性冠脉综合征(NSTE-ACS)患者使用抗凝药物磺达肝癸钠,随访患者的不良心血管事件和出血的发生率,并与依诺肝素作对比分析。方法入选了确诊为NSTE-ACS患者70例,均给予常规药物治疗,并随机分为两组:A组(36例),加用磺达肝癸钠(安卓)2.5mg,每天皮下注射1次,用药7d;B组(34例),加用依诺肝素1mg/kg,每天皮下注射2次,用药7d;两组此后均行PCI治疗,术中均应用常规剂量肝素(85IU/Kg),术后继续使用磺达肝癸钠或依诺肝素。观察两组患者第9d、30d、90d时的不良心血管事件和出血的发生率。结果①磺达肝癸钠组与依诺肝素组的不良心血管事件的发生率比较差异无统计学意义(P>0.05)。②磺达肝癸钠组和依诺肝素组的出血发生率比较差异有统计学意义(P<0.05)。③两组复合终点比较差异有统计学意义(χ2=12.59,P<0.05)。结论①在NSTE-ACS患者中行PCI治疗前应用磺达肝癸钠疗效等同于依诺肝素。②磺达肝癸钠应用于NSTE-ACS患者有良好的安全性,出血不良反应少。
作者 赵琳 汤建民
出处 《中国实用医药》 2012年第17期127-129,共3页 China Practical Medicine
  • 相关文献

参考文献10

  • 1Eikelboom JW,Mehta SR,Anand SS,et al.Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.Circulation,2006,114:774-782.
  • 2欧洲心脏病学会非ST段急性冠脉综合征治疗指南工作组,ESC非ST段抬高急性冠脉综合征治疗指南,(颜红兵、杨艳敏)[医学卫生]医心评论,2011:8-9.
  • 3The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.Guidelines for Percutaneous Coronary Interventions.European Heart Journal,2005,(26),804-847.
  • 4The OASIS-6 Trial Group.Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction.JAMA,2006,295(13):1519-1530.
  • 5Stone GW,McLaurin BT,Cox DA,at al.Bivalirudin for patients with acute coronary syndromes.N Engl J Med,2006,355:2203-2216.
  • 6Simoons ML,Bobbink IW,Boland J,et al.A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes:the Pentasaccharide in Unstable Angina(PENTUA)Study.J Am Coll Cardiol,2004,43(12):2183-2190.
  • 7Harrington RA,Becker RC,Cannon CP,et al.Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition).Chest,2008,133(6 Suppl):670-707.
  • 8Antman EM,Hand M,Armstrong PW,et al.2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2008,51(2):210-247.
  • 9Canadian Cardiovascular Society,American Academy of Family Physicians,American College of Cardiology,et al.Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation:the Task Force on the 17 Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.Eur Heart J,2008,29(23):2909-2945.
  • 10Mehta SR,Boden WE,Eikelboom JW,et al.Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST and non-ST-segment elevation acute coronary syndromes:an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes(OASIS 5 and 6) randomized trials.Circulation,2008,118(20):2038-4618.

同被引文献56

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部